Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review-Reference-Cited by-同舟云学术

Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review

Published:2021-12 Issue:12 Volume:21 Page:e387-e398
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Deal Anna^ORCID,Halliday Rae,Crawshaw Alison F^ORCID,Hayward Sally E^ORCID,Burnard Amelia,Rustage Kieran,Carter Jessica,Mehrotra Anushka,Knights Felicity,Campos-Matos Ines,Majeed Azeem,Friedland Jon S,Edelstein Michael,Mounier-Jack Sandra,Hargreaves Sally^ORCID

Funder

NIHR

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference89 articles.

1. Evolving migrant crisis in Europe: implications for health systems;Carballo;Lancet Glob Health,2017

2. World migration report,2020

3. Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence;Mipatrini;Pathog Glob Health,2017

4. Migrant and refugee populations: a public health and policy perspective on a continuing global crisis;Abbas;Antimicrob Resist Infect Control,2018

5. European vaccine action plan 2015–2020,2014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Vaccination Challenges among Syrian Refugees in Jordan: Insights from Camps and Communities, and Perceived Parental Barriers to Childhood Vaccination Uptake;Vaccines;2024-01-27

2. COVID-19 vaccination coverage for half a million non-EU migrants and refugees in England;Nature Human Behaviour;2023-12-04

3. Assessment of willingness and determinants to receive the COVID-19 vaccine among the general population of the Somali region, Eastern Ethiopia: a 2021 cross-sectional study;BMJ Open;2023-12

4. Ukrainian migrants’ and war refugees’ admissions to hospital: evidence from the Polish Nationwide General Hospital Morbidity Study, 2014–2022;BMC Public Health;2023-11-24

5. Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals;Frontiers in Immunology;2023-11-02